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Background: Haemoglobinuria is one of the manifestations of severe malaria and results from severe intravascular
haemolysis. Glucose-6-phosphate dehydrogenase (G6PD) deficiency has been implicated in its aetiology.
Haemoglobinuria may be associated with severe anaemia and, less frequently, acute renal failure.
Methods: A prospective case-control study was carried out to determine the incidence of haemoglobinuria as
confirmed by dipstick urinalysis, microscopy and spectrophotometric measurement, among children with severe
malaria. A total of 251 children presenting at the Children’s Emergency Ward with severe malaria were recruited
over a period of 21 months. The G6PD status and the outcomes of severe malaria in children with and without
haemoglobinuria was studied with respect to renal failure, the recurrence of haemoglobinuria and blood pressure
changes over a three-month follow-up period.
Results: It was found that the incidence of haemoglobinuria among children with severe malaria is 19.1%. Children
<5 years constituted 76.8% of all the study patients. Patients with haemoglobinuria had median age of 52.5
months, which was significantly higher than 35 months in patients without haemoglobinuria (p=0.001). Although,
haemaglobinuria was commoner among boys (54.2%) than girls (45.8%), the difference was not statistically
significant. There were no significant differences between children with and without haemoglobinuria regarding
their nutritional status or parasite densities. Among the clinical features of the study patients, only jaundice was
significantly associated with haemoglobinuria (p=0.0001). Renal failure occurred in three out of 48 children with
haemoglobinuria and in none of the 203 without. There was not recurrence of haemoglobinuria in the follow-up
period. At discharge, blood pressure was elevated in six children (one previously haemoglobinuric), but all returned
to normal within the follow-up period.
Conclusions: Haemoglobinuria was a prominent feature of severe malaria and it was significantly associated with
jaundice at presentation. Haemoglobinuria was commoner in older children than younger children but not related
to sex. G6PD deficiency was not an independent predictor of the occurrence or outcome of haemoglobinuria.
Blood pressure was not affected by haemoglobinuria on admission nor during follow-up.
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It is estimated that 300 million clinical cases of malaria
occur each year in malaria-endemic regions. Most of the
deaths from malaria are due to the severe forms of the
disease, especially cerebral malaria and severe malarial
anaemia [1]. Recent reports point to a reduction of mal-
aria cases in parts of Africa [2]. However, Nigeria, the
most populous country of Africa, accounts for a quarter
of the global cases and a third of the malaria-attributable
childhood deaths [1,3-5]. In Nigeria, Plasmodium falcip-
arum accounts for 96-98% of malaria infections, while
other infections are due to Plasmodium malariae [6,7].
Malarial illnesses may take a variety of clinical forms,
differing in pattern and severity, from uncomplicated to
severe and complicated malaria. Severe falciparum mal-
aria may manifest with wide variety of features as
described by WHO haemoglobinuria being one of them
[8]. Haemoglobinuria occurs when the capacity of
haptoglobin to bind free haemoglobin is exceeded. Des-
pite their sometimes similar visual appearances, the ab-
sence of red blood cells on microscopic examination
distinguishes haemoglobinuria from haematuria.
Retrospective studies of malaria have reported haemo-
globinuria incidence in adults ranging from 15% to 63%
[9,10]. Some other studies have documented haemo-
globinuria as rare in children [11,12] while other studies
have reported incidence rates ranging from 2% to 17%
[13-16] across different malaria-endemic regions. A mul-
ticentre study [17] of severe malaria among children in
10 African countries, Nigeria inclusive, reported a mean
haemoglobinuria prevalence of 3.3%. Similarly, a pro-
spective study of 627 children with confirmed diagnosis
of malaria in Maiduguri, Nigeria, found haemoglobinuria
in 3.7% of the patients [18]. A common problem of these
studies is that they do not indicate the number of severe
malaria patients included in the analyses.
Several factors such as immune hypersensitivity in
long-term residents of P. falciparum-endemic areas who
took quinine irregularly or glucose-6-phosphate de-
hydrogenase (G6PD) deficiency have been implicated in
the aetiology of haemoglobinuria. Haemoglobinuria can
also occur in patients with normal erythrocyte G6PD
levels who receive quinine for severe malaria [19,20].
However, there is lack of current data from prospective
studies regarding the correlation between haemoglobin-
uria and severe malaria, with or without G6PD defi-
ciency, in Nigerian children [21].
The clinical features peculiar to malaria-induced
haemoglobinuria are mainly features of intravascular
haemolysis and these features may be associated with
anaemia. They generally include fever, abdominal pain,
back pain or pain in the limbs, dyspnoea, tachycardia, a
non-specific complaint of generalized malaise or dizzi-
ness [7,22]. Shock and renal failure can occur. However,in some cases, patients can be asymptomatic, their pallor
being only detected by family members or other indivi-
duals. The most consistent findings in malaria haemo-
globinuria are fever, pallor, jaundice and passage of dark
urine [8].
Haemoglobinuria was previously thought to be in-
nocuous and self-limiting, usually resolving within three
days of onset. However, studies have shown that haemo-
gobinuria may result in acute renal failure. Krishna and
Karnad [10] in a prospective study of 301 severe malaria
patients in India reported that haemogobinuria
accounted or 33% of the mortality.
The prevalence of haemoglobinuria, its clinical profile,
the associated frequency of G6PD deficiency and its
effects on the outcome of severe malaria among Niger-
ian children, are unknown. In the present study, haemo-
globinuria among children with severe malaria was
prospectively investigated using a quantitative spectro-
photometric method [23] as distinct from qualitative
spectroscopic detection. The incidence of haemoglobin-
uria, its association with clinical features of malaria and
the G6PD status was documented among children with
severe malaria attending the tertiary care facility at the
University College Hospital, Ibadan.
Methods
Study site
All study participants were recruited under the auspices
of the Childhood Malaria Research Group (CMRG) at
the 600-bed tertiary hospital, University College Hospital
(UCH) in the city of Ibadan, Nigeria in west sub-Saharan
Africa. Ibadan is the capital city of Oyo State in the
South-West of Nigeria. It has a population of 2,550,293
people and annual growth rate of 2.83% (2006 census)
[24]. The population of Ibadan comprises predominantly
the Yoruba-speaking people of the western Nigeria.
This study was carried out at the Otunba Tunwase
Children Emergency Ward (OTCHEW) of the Depart-
ment of Paediatrics of the University College Hospital,
Ibadan. The OTCHEW is one of the six wards in the
Department of Paediatrics and it has thirty-five bed-
spaces for admission. The number of admissions per
year is approximately 2,000. About twice that number
are treated there without needing admission.
Study design and case definitions
This was a prospective case control study. After obtain-
ing informed consent, children were recruited between
the ages of six months and twelve years using WHO se-
vere malaria criteria [8]. Cerebral malaria (CM) cases
were defined as children in unrousable coma for at least
one hour in the presence of asexual P. falciparum para-
sitaemia with normal cerebrospinal fluid. A Blantyre
coma score less or equal to 2 was used to define coma
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as conscious children with packed cell volume (PCV)
less than 16% in the presence of P. falciparum parasit-
aemia. Other forms of severe malaria (OFSM) were
defined according to WHO criteria [8] and required
hospitalization. These included children with prostra-
tion, haemoglobinuria, two or more seizures within 24 h
or hyperpyrexia. Renal failure was defined as urine out-
put <12 ml/kg/24 h or a plasma creatinine concentration
above the age-related normal range, persisting after re-
hydration [8].
The cases were defined as children with severe malaria
presenting with haemoglobinuria. Age- and sex-matched
severe malaria patients without haemoglbinuria served
as controls. Age matching criteria were +/− three
months for six to 24 months and +/− six months for
older children. Children were excluded from the study if
they had been transfused within three months before
presentation, or there was history of severe trauma or
burns within the preceding month or they had a haemo-
globinopathy or they presented with haematuria.
Peripheral blood films, thick and thin, for microscopic
examination for malaria parasites were carried out on
admission. About 5ml of venous blood was withdrawn
from each study participant into EDTA tubes for haemo-
globin electrophoresis and G6PD screening. The blood
pressure of each patient presenting with severe malaria
was measured on admission.
Dipstick urinalysis was carried out in all enrolled chil-
dren. Urine samples that tested positive for blood were
divided into two aliquots. Urine microscopy was carried
out on one aliquot to exclude haematuria while the sec-
ond was preserved at −20°C to measure haemoblogin
concentration. Urine racks containing aliquots from
each time the child passed urine, were kept for all
patients with dark coloured urine to monitor the clear-
ing of the urine.
Children with haemoglobinuria and their matched
controls were followed up during the 2nd, 4th, 8th and
12th weeks after recruitment. At each follow-up clinic
visit, children were screened for malaria parasites and
their clinical status, including blood pressure measure-
ments, was documented. Urinalysis was repeated for
both the cases and the controls. Those who tested posi-
tive for blood had urine microscopy repeated to exclude
haematuria.
Urine collection procedure and urinalysis
About 10ml of urine was collected and subjected to
urinalysis immediately. Otherwise, it was stored in the
fridge at 4°C and the urinalysis done within 24 h. Multi-
stix strip (DIALAB Ref G04010C) [25] was completely
immersed in each of the urine samples, in clean univer-
sal bottles, after gently but thoroughly shaking thesample. Samples testing positive for blood were divided
into two. Half of the sample was immediately sent to the
microbiology laboratory for urine microscopy. The other
half was preserved at −20°C for spectrophotometry in
batches. Haemoglobinuria was assessed using the rate
spectrophotometry method described by Chalmer and
Snell [23].
Data collection procedure
Each child’s caregiver was interviewed using a structured
project questionnaire. History was obtained from the
caregiver and, if old enough, the child. A complete phys-
ical examination was carried out on each patient. All
findings from physical examination and other relevant
information including the results of G6PD test, PCV,
parasite counts, haemoglobin electrophoresis were
recorded into the structured project questionnaire.
Packed cell volume
PCV was determined using the capillary method and
spinning in a Hawksley micro-haematocrit centrifuge at
11,000g for 5 min at room temperature. The packed cell
volume was then read with a haematocrit reader.
Malaria parasite screening
Thick and thin films were made on the same slide for
each patient. The thin film was fixed with methanol im-
mediately and the slide was allowed to dry, then flooded
with Giemsa already diluted 1 in 10 with phosphate buf-
fer, pH 7.2. The stain was washed off with distilled water,
after allowing it to stand for about 10 min, and then air-
dried. The stained films were then examined microscop-
ically for malaria parasites using a x100 objective (oil
immersion) and x10 eye piece lenses i.e. total magnifica-
tion of x1,000. The parasites were counted against 200
white blood cells (WBC) and parasite density was calcu-
lated for each patient based on an assumed total WBC
of 8000/μL of blood.
Determination of G6PD status by fluorescent spot test
G6PD status of recruited children was determined
using the fluorescent spot test method of Beutler and
Mitchell [26].
Data management and analysis
Data was entered into a microcomputer and analyzed
using the Epi-Info Version 6 and SPSS 11.0 for windows.
Categorical variables were compared using either the un-
corrected chi-square test or Fisher’s exact test while con-
tinuous variables were analyzed using the Student’s t-
test. Data not normally distributed were compared using
the Mann-Whitney U-test. Continuous variable esti-
mates were expressed as mean (±SD) or median (inter-
quartile range) while categorical variables were in
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cance level was set at p<0.05.
Results
Characteristics of study patients
A total of 265 children with severe malaria were
screened over a period of 21 months (January 2006 to
September 2007) and 251 eligible children were
recruited into this study. These comprise 102 (40.6%)
females and 149 (59.4%) males giving a female to male
ratio of 1:1.5 (Table 1). The remaining 14 patients were
excluded due to incomplete data. The 265 severe malaria
patients represented 3.05% of the 8,705 children with
malaria-positive smears seen over the study period.
The characteristics of the studied patients are sum-
marized in Table 1. Forty-eight (19.1%) of the patients
had haemoglobinuria. These consisted of 22 (45.8%)
females and 26 (54.2%) males. Overall, the ages of the
patients ranged between six months and 12 years with
the median age being 36 months. The median age of the
patients with haemoglobinuria was 52.5 months,Table 1 Characteristics of study patients
Positive
Number of Patients N (%) 48 (19.1)
Sex Ratio Female : Male 22 : 26
Age Months Median (IQR) 52.5 (18–138)
Age Distribution N (%)
6–11 months 0 (0)
12–23 months 4 (8.3)
24–35 months 12 (25)
36–47 months 6 (12.5)
48–59 months 8 (16.7)
> 59 months 18 (37.5)
Weight for Age [z-score] Median (IQR) −1.32 (−5.38 - 1.45
Parasite Density Geometric Mean Range 8960.9
607–198,606
G6PD Status Deficient : Normal N(%)
Males 4 : 22 (15 : 85)
Females 0 : 22 (0 : 100)
Clinical forms of Severe Malaria N (%)
Cerebral Malaria 17 (35.4)
Severe Malarial Anaemia 13 (27.1)




* p significant at < 0.05.
** Postration (82%); Haemaglobinuria (8%); Seizures >2 episodes/day (5%); Hyperpysignificantly higher than 35 months in patients without
haemoglobinuria (p = 0.001). Infants aged six to 11
months constituted 7.2% of the study patients. Children
under five years of age (6 to 59 months) constituted
76.8% of all the study patients. Children over five years
of age constituted 23.2% of all patients (Table 1). A sig-
nificantly higher proportion (37.5%) of patients with hae-
mogobinuria were five years and older, compared to
(19.7%) in patients without haemoglobinuria (Table 1).
There was no statistically significant difference in the
age distribution of patients by gender. The patients’
weights ranged from 5.6kg to 72.5kg with an overall
mean weight of 13.74±6.3kg. The mean weight for the
patients with haemoglobinuria was 15.29±5.5kg com-
pared with 13.38±6.4kg in those without haemoglobin-
uria. The mean weight–for-age Z-score of all patients
was −1.36. The median weight for age Z-scores were
−1.32 and −1.31 among the patients with haemoglobin-
uria and patients without haemoglobinuria, respectively
(Table 1). There was no statistically significant difference
in the nutritional status of patients with and withoutHaemoglobinuria All
Negative
203 (80.9) 251
80 : 123 102 : 149
35 (7–137)* 36 (7–138)
18 (8.9) 18 (7.2)
42 (20.7) 46 (18.3)
43 (21.2) 55 (21.9)
33 (16.3) 39 (15.5)
27 (13.3) 35 (13.9)
40 (19.7) 58 (23.2)
) −1.31 (−6.22 - 4.06) −1.31 (−6.22 - 4.06)
9209.6 9161.5
64–192,000 64-198606
15 : 108 (12 : 88) 19 : 130 (13 : 87)
4 : 76 (5 : 95) 4 : 98 (4 : 96)
70 (34.5) 87 (34.7)
90 (44.3) 103 (41)
43 (21.w) 61 (24.3)
189 (93.1) 231 (92)
14 (6.9) 20 (8)
rexia (5%).
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parasite counts of patients with haemoglobinuria were
slightly lower than those without haemoglobinuria, but
these were not statistically significant (Table 1). There
was no significant difference in the G6PD status of
patients with or without haemoglobinuria even after
stratifying according to gender. However, it is note-
worthy that all the G6PD deficient patients who had
haemoglobinuria were males (Table 1).
Clinical forms of severe malaria
The distributions of patients by clinical forms of severe
malaria are shown in Table 1. Generally, CM, SMA and
OFSM accounted for 34.7%, 41% and 24.3% of the study
patients respectively. Among those with haemoglobin-
uria, CM, SMA and OFSM accounted for 35.4%, 27.1%
and 37.5% respectively. All the patients with CM were
treated with intravenous quinine (according to the Ni-
gerian national policy at the time) and none developed
haemoglobinuria during treatment. Those who pre-
sented with haemoglobinuria did not have their condi-
tion worsened by quinine treatment.
The overall mortality in this study was 20 (8%). These
consisted of 6 (12.5%) of the 48 patients with haemo-
globinuria compared with 14 (6.9%) of the 203 patients
without haemoglobinuria (Table 1). Haemoglobinuria
was present in 30% of the patients who died. The differ-
ence in mortality between patients with versus without
haemoglobinuria was not statistically significant. One of
the dead patients with haemoglobinuria had anuric acute
renal failure, while the other two patients who developed
renal failure secondary to malarial haemoglobinuria sur-
vived after dialysis. This showed that acute renal failure
occurred in 6.25% of the patients with haemoglobinuria
and 1.2% of all the severe malaria patients. None of the
patients without haemoglobinuria had acute renal fail-
ure. The distribution of the mortality among CM, SMA
and OFSM was 11 (55%), five (25%) and four (20%) of
the total mortality respectively.
Clinical features
The comparisons of the clinical features of malaria in
patients with and without haemoglobinuria are shown in
Table 2. The proportion of patients who presented with
vomiting, pallor, passage of dark urine or reduced urine
frequency was higher in patients with haemoglobinuria
than patients without haemoglobinuria. However, a sta-
tistically significance difference was only seen with jaun-
dice and passage of dark urine (Table 2). The
proportions of other symptoms and signs were similar
between the two groups.
On admission, 48 of the 251 severe malaria patients
had their urine testing positive for haemoglobin and
had haematuria excluded by urine microscopy. Thehaemoglobin concentrations of urine samples of 45 of
the patients with haemoglobinuria ranged from 5 to
6,800mg/l (median 400mg/l). Three samples were lost
during storage.
Follow-up
Out of the 42 patients with haemoglobinuria who sur-
vived 19 (45%), 29 (69%), 13 (31%) and 27 (64%) were
followed up at two weeks, four weeks, eight weeks and
12 weeks respectively. For those without haemoglobin-
uria 24 (12.6%), 39 (20.6%), nine (4.7%) and 44 (23.2%)
were followed up at 2, 4, 8 and 12 weeks respectively.
The follow-up at three months involved 15 males
(55.6%) and 12 (44.4%) females with haemoglobinuria
and 30 (68.2%) males and 14 (31.8%) without haemo-
globinuria. Two of the patients with haemoglobinuria
had recurrent haemoglobinuria at one month while
haemoglobinuria never occurred in the group of patients
without initial haemoglobinuria.
The blood pressures of the study patients on admis-
sion and during follow-up are shown in Table 3. There
was no significant difference in the mean systolic or dia-
stolic blood pressures of patients with or without
haemoglobinuria on admission and follow-up at one
month and three months (Table 3). Only 6 (2.3%) of the
study patients had transient elevated blood pressure on
admission. These comprised 1 (2.1%) of the patients
with haemoglobinuria and 5 (2.5%) of the patients with-
out haemoglobinuria. Subsequently, the blood pressures
of all the studied patients were normal.
Discussion
The present study has shown that the incidence of
haemoglobinuria among children with severe malaria is
19.1%. This value is higher than the previously reported
range of 2% to 17% [9,14,17,18] but lower than other
studies in adults which reported incidence ranging from
63% to 70% [10,13]. The different figures from previous
studies could be due to the fact that haemoglobinuria
was diagnosed only by visual inspection of the urine
samples, or the inclusion of all malaria cases as the de-
nominator. On the contrary, we have focused only on
those children with severe malaria. All our haemoglobi-
nuric patients had dark urine at admission. Although we
cannot exclude concomitant myoglobinuria, previous
studies have reported that dark urine is generally the re-
sult of intravascular haemolysis [22].
There was a significant difference in the age-
distribution of patients with or without haemoglobin-
uria. The proportion of children above five years with
haemoglobinuria was higher than those without haemo-
globinuria. This finding suggests that haemoglobinuria
may be commoner in children above five years. A previ-
ous prospective study reported a higher incidence of
Table 2 Symptoms and signs of study patients
Haemoglobinuria OR 95% CI
Positive Negative
Presenting Complains N (%)
Vomiting 36 (75) 127 (62.6) 1.8 0.83 - 3.93
Pallor 36 (75) 139 (68.5) 1.38 0.64 - 3.04
Yellowness of the eyes 21 (43.8) 44 (21.7) 2.81* 1.37 - 5.77
Difficulty with breathing 13 (27.1) 73 (36) 0.66 0.31 - 1.41
Passage of dark urine 35 (72.9) 49 (24.1) 8.46* 3.91 - 18.56
Convulsion 22 (45.8) 109 (53.7) 0.77 0.38 - 1.37
Body swelling 2 (4.2) 8 (3.9) 1.06 0–5.73
Reduced frequency of urination 4 (8.3) 13 (6.4) 1.33 0.34 - 4.72
Clinical Signs N (%)
Pallor 39 (81.3) 160 (78.8) 1.16 0.49 - 2.83
Temperature > 37.4 C 40 (83.3) 166 (81.8) 1.11 0.48 - 2.57
Liver size > 2cm 32 (66.7) 127 (62.6) 1.19 0.61 - 2.32
Splenomegaly 10 (20.8) 66 (32.5) 0.54 0.25 - 1.16
Jaundice 28 (58.3) 55 (27.1) 3.77* 1.86 - 7.67
Respiratory distress 14 (29.2) 71 (35) 0.76 0.38 - 1.52
* p significant at < 0.05.
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[27]. However, that study only used dipstick to verify
diagnosis of haemoglobinuria and therefore it cannot ex-
clude microscopic haematuria. However in the present
study a more accurate estimate of haemoglobinuria was
obtained by combining urine dipstick testing with mi-
croscopy and spectrophotometric methods.
The proportion of boys in our study was higher than
girls, a finding that is consistent with previous studies
from the same centre [28,29]. Though the proportion of
males with haemoglobinuria was higher than females,
there was no significant gender predominance amongTable 3 Blood Pressures of Study Participants
Haemoglobinuria
Positive Negative
BP at Admission mean (sd)
Systolic 94.3 (10.8) 92.1 (10.1)
Diastolic 55.4 (6.8) 55.2 (8.2)
BP at 1 Month mean (sd)
Systolic 93.1 (6.5) 91.9 (6.9)
Diastolic 57.6 (6.4) 56.2 (6.3)
BP at 3 Months mean (sd)
Systolic 90 (6.9) 90.3 (7.1)
Diastolic 56 (6.4) 57.6 (5.9)the patients with or without haemoglobinuria. The gen-
der distribution of subjects enrolled for this study
reflected the general pattern of admissions into the
emergency ward.
There was no significant difference in the nutritional
status of patients with or without haemoglobinuria. The
weight-for-age z-score was consistent with previous find-
ings that severe malaria generally occurring in children
whose nutritional is within normal limits [28,30].
Almost half of the study subjects were SMA patients,
similar to what has been reported in studies from Yemen
[31], Sudan [32], and Uganda [14].
Jaundice was significantly associated with haemo-
globinuria, which is in accordance with previous studies
on blackwater fever that have reported jaundice and pal-
lor as major manifestations [7,20,33,34]. Although not
statistically significant, a higher proportion of patients
with clinical pallor were observed among the haemo-
globinuria group.
Occurrence of haemoglobinuria has been previously
linked with parasitaemia. While some researchers have
associated blackwater fever with scanty or no parasit-
aemia [7,20], others reported higher incidence rates of
haemoglobinuria in areas of high malaria transmission
and parasitaemia [27]. However, a previous study in
Uganda showed no significant difference in the preva-
lence of haemoglobinuria in areas with low, moderate or
high parasite transmission [16]. The present study did
not show any significant difference in the parasite dens-
ity of patients with or without haemoglobinuria in this
urban area of high malaria transmission. It is, therefore,
not likely that the parasite density alone could explain
the high frequency of haemoglobinuria found in the
present study.
The frequency of G6PD deficiency among severe mal-
aria patients in the present study was 9.2%. This was
close to the frequency of 6% reported from the same
centre in the 1960’s [35]. The frequency of G6PD defi-
ciency was higher among boys compared to girls. This is
consistent with the distribution pattern of G6PD defi-
ciency in this population. G6PD deficiency being a sex-
linked disorder occurs more commonly in the male
population. The G6PD deficiency frequency was signifi-
cantly lower in our hospital population than the one
obtained from a previous study of a healthy homogenous
population in the community [36]. Virtually by defin-
ition, hospital populations are already selected by their
help-seeking behaviour due to illness (malaria in this
case). In the present study, they have further been
selected by the admission criteria. Thus, the observed
reduced frequency of G6PD-deficiency is consistent with
the hypothesis that G6PD-deficiency protects against se-
vere malaria. There was no significant difference in the
G6PD status of patients with or without haemoglobinuria
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ference in the occurrence of haemoglobinuria between
G6PD-normal and deficient children suggests that G6PD
deficiency is not a significant independent determinant
in patients with severe malaria.
Previous studies have implicated the repeated exposure to
quinine in the aetiology of Blackwater fever [7,20,34]. We
cannot comment on the role of previously administered
quinine in the pre-hospital appearance of haemoglobinuria.
However, none of the CM patients who presented without
haemoglobinuria and were treated with quinine, developed
haemoglobinuria. In addition, haemoglobinuria was not
worsened among the CM patients who had haemoglobin-
uria on admission and were treated with quinine. In any
case, since the completion of this study, in the revised Na-
tional Malaria Policy, Quinine is no longer recommended
for routine use as a first-line drug in the treatment of CM.
Thus, the risk of repeated exposure to quinine is minimal.
The overall mortality rate of severe malaria from this
study was 8% with CM accounting for majority of the cases;
this finding is consistent with previous studies [17]. Haemo-
globinuria was present in 30% of the dead patients. One of
the dead patients with haemoglobinuria had anuric acute
renal failure while the other two patients who developed
renal failure secondary to malarial haemoglobinuria sur-
vived after dialysis. Acute renal failure occurred in 6.25% of
the patients with haemoglobinuria and 1.2% of all the se-
vere malaria patients. The inference that can be drawn from
the above findings is that haemoglobinuria is not as innocu-
ous as earlier thought and that malaria- induced acute renal
failure should be sought and treated promptly since, 1
(33.3%) of the patients that developed renal failure died.
Moreover, haemoglobinuria should be handled with fervent
seriousness because all the three patients that had acute
renal failure had haemoglobinuria.
The urine of all the patients with haemoglobinuria be-
came visually clear over a period of three days. Compari-
son of the blood pressure of patients with or without
haemoglobinuria showed no significant difference on ad-
mission and during follow-up. Even the three patients
who had renal failure had normal blood pressure on ad-
mission. Of these, the two survivors had normal blood
pressure throughout the follow-up period. In all six chil-
dren (one in the group with haemoglobinuria) who had
mild elevation of blood pressure in the acute phase, the
blood pressure returned to normal within the follow-up
period. This indicates that blood pressure elevation in
severe falciparum malaria is transient. However, our
period of observation (follow-up) was limited to three
months. The possibility of subsequent blood pressure
elevation during longer follow-up cannot be excluded.
The mechanism of this blood pressure elevation is not
clear. The proportions involved are small. But if any-
thing, it is slightly lower in the haemoglobinuric group(1/48 ie 2.1%) than the group without haemoglobinuria
(5/203 ie 2.5%). This suggests that direct toxicity of free
haemoglobin on renal tissues is not likely to be a major
factor. Since P. falciparum is known to exhibit cytoad-
herrence in deep vascular tissues, it is tempting to
speculate that the ischaemia consequent upon cytoad-
herence in the renal vasculature stimulates the rennin-
angiotensin mechanism, which raises the blood pressure.
The rapid resolution of the rise in blood pressure is con-
sistent with the idea of a rapid reversal of the renal vas-
cular cytoadherence and ischaemia following the
clearance of the parasitaemia.
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